Transparency

Perspectives & insights

July 18, 2025

Transparency Report shows need for patient-centered reform

Transparency Report & Issue Briefs

September 1, 2024

2023 Johnson & Johnson Innovative Medicine U.S. pricing transparency report

Creating the next era of healthcare advancements for patients

Transparency Report & Issue Briefs

September 1, 2024

$42.8 billion: Breaking it down

2023 Rebates, discounts and fees

Transparency Report & Issue Briefs

September 1, 2024

2023 rebates, discounts and fees

Transparency Report & Issue Briefs

January 1, 2023

The 2022 Janssen U.S. Pricing Transparency Brief

Transparency Report & Issue Briefs

January 1, 2022

The 2021 Janssen U.S. Transparency Report

Transparency Report & Issue Briefs

January 1, 2022

The 340B Program: Issue brief

How arbitrage, opportunism and opacity undermine the Program’s original purpose

Transparency Report & Issue Briefs

January 1, 2021

The 2020 Janssen U.S. Transparency Report

Building a healthier future for all

Transparency Report & Issue Briefs

March 1, 2020

2019 Janssen U.S. Transparency Report

Transforming lives, advancing hope

Transparency Report & Issue Briefs

May 1, 2019

2018 Janssen U.S. Transparency Report